GlassScriptPhysician profile
Mark S Sanders
NPI 1871546218
$17,609.82
in general payments reported to CMS, 2019-2025
18 companies · $3,031 in 2025
The $3,031 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,197 · 2020: $121 · 2021: $2,044 · 2022: $2,467 · 2023: $2,277 · 2024: $4,472 · 2025: $3,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,143 · Travel and Lodging: $4,557 · Education: $81.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,142.52 |
| Travel and Lodging | $4,557.07 |
| Education | $81.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,011.70 | 2020-2025 | Infinity, Augment Injectable, Inbone |
| Paragon 28, INC. | $4,390.03 | 2021-2024 | Portfolio, Apex 3d |
| Treace Medical Concepts, INC. | $2,173.09 | 2021-2025 | |
| Medinc of Texas | $1,791.07 | 2019-2025 | |
| Trimed, INC. | $1,436.83 | 2019 | |
| Exactech, INC. | $715.79 | 2022 | |
| Medshape, INC. | $345.28 | 2022-2024 | Dynanail |
| Smith+Nephew, INC. | $179.44 | 2019-2025 | Stravix |
| Arthrex, INC. | $146.00 | 2025 | Arthrex |
| Carbofix Orthopedics INC | $130.80 | 2025 | |
| Vericel Corporation | $89.38 | 2020-2023 | Maci |
| Medical Device Business Services, INC. | $41.50 | 2024 | |
| Catalyst Orthoscience | $38.96 | 2021 | |
| Alafair Biosciences, INC. | $37.64 | 2024 | Versawrap |
| Depuy Synthes Sales INC. | $31.82 | 2024 | Vivigen Mis Delivery System, Hammerlock |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $20.42 | 2024 | Irrisept |
| Lilly USA, LLC | $16.98 | 2022 | |
| Aytu Biopharma, INC. | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.